Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is relevant for the prognosis in patients with RA. Nintedanib, which inhibits both receptor and non-receptor type tyrosine kinases, is an antifibrotic drug for the treatment of progressive fibrosing ILDs, such as idiopathic pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Yoko, Ohkubo, Hirotsugu, Niimi, Akio, Kanazawa, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646002/
https://www.ncbi.nlm.nih.gov/pubmed/34881329
http://dx.doi.org/10.1183/23120541.00345-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646002/
https://www.ncbi.nlm.nih.gov/pubmed/34881329
http://dx.doi.org/10.1183/23120541.00345-2021

Ejemplares similares